Authors: Hamill, TG Duggan, ME Perkins, JJ

Citation: Tg. Hamill et al., The synthesis of the alpha(v)beta(3) integrin receptor ligand [I-125]L-775,219., J LABEL C R, 44(1), 2001, pp. 55-59

Authors: Hartman, GD Duggan, ME

Citation: Gd. Hartman et Me. Duggan, alpha(v)beta(3) integrin antagonists as inhibitors of bone resorption, EXPERT OP I, 9(6), 2000, pp. 1281-1291

Authors: Duggan, ME Hutchinson, JH

Citation: Me. Duggan et Jh. Hutchinson, Ligands to the integrin receptor alpha(v)beta(3), EXPERT OP T, 10(9), 2000, pp. 1367-1383

Authors: Egbertson, MS Bednar, B Askew, BC Bednar, RA Brashear, K Breslin, MJ Duggan, ME Fisher, TE Halczenko, W Hutchinson, JH Ihle, N Prugh, JD Wai, JS Gould, RJ Hartman, GD

Citation: Ms. Egbertson et al., Nonpeptide GPIIB/IIIA receptor antagonists. Part 21: C-6 flexibility and amide bond orientation are important factors in determining the affinity of compounds for activated or resting platelet receptors, BIOORG MED, 10(17), 2000, pp. 1943-1948

Authors: Duggan, ME Duong, LT Fisher, JE Hamill, TG Hoffman, WF Huff, JR Ihle, NC Leu, CT Nagy, RM Perkins, JJ Rodan, SB Wesolowski, G Whitman, DB Zartman, AE Rodan, GA Hartman, GD

Citation: Me. Duggan et al., Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist, J MED CHEM, 43(20), 2000, pp. 3736-3745

Authors: Hartman, GD Duggan, ME Hoffman, WF Meissner, RJ Perkins, JJ Zartman, AE Naylor-Olsen, AM Cook, JJ Glass, JD Lynch, RJ Zhang, GX Gould, RJ

Citation: Gd. Hartman et al., Nonpeptide glycoprotein IIB/IIIA inhibitors. 19. A new design paradigm employing linearly minimized, centrally constrained, exosite inhibitors., BIOORG MED, 9(6), 1999, pp. 863-868